Panaxtriol
CAS No. 32791-84-7
Panaxtriol( —— )
Catalog No. M18426 CAS No. 32791-84-7
Panaxatriol can relieve myelosuppression induced by radiation injury.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | In Stock |
|
| 5MG | 82 | In Stock |
|
| 10MG | 101 | In Stock |
|
| 25MG | 242 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePanaxtriol
-
NoteResearch use only, not for human use.
-
Brief DescriptionPanaxatriol can relieve myelosuppression induced by radiation injury.
-
DescriptionPanaxatriol can relieve myelosuppression induced by radiation injury.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetAdrenergic Receptor
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number32791-84-7
-
Formula Weight476.39
-
Molecular FormulaC30H52O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (52.44 mM)
-
SMILESC[C@@]1(CCCC(O1)(C)C)[C@H]2CC[C@@]3([C@@H]2[C@@H](C[C@H]4[C@]3(C[C@H]([C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)O)C)O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cheng Y, Shen LH, Zhang JT. Acta Pharmacol Sin. 2005 Feb;26(2):143-9.
molnova catalog
related products
-
Fostemsavir
BMS-663068 is an HIV-1 attachment inhibitor in development for the treatment of HIV-1 infection.
-
BRL 44408
A potent, selective α2A-adrenoceptor antagonist with Ki of 1.7 nM, 80-fold selectivity over α2B-adrenergic receptors.
-
Dibenamine hydrochlo...
Dibenamine hydrochloride is a competitive and irreversible blocking agent of the β-adrenergic receptor.
Cart
sales@molnova.com